Kingswood Wealth Advisors LLC Grows Stock Holdings in Amprius Technologies, Inc. $AMPX

Key Points

• Kingswood Wealth Advisors LLC increased its ownership in Amprius Technologies by 44.7% during the second quarter, bringing its total shares to 85,408, valued at approximately $360,000.
• CEO Kang Sun and CFO Sandra Wallach both sold shares of Amprius Technologies on August 21st, with Sun selling 65,654 shares for about $447,760, reducing his ownership by 4.27%.
• Analysts have positive outlooks for Amprius Technologies, with multiple brokerages issuing "buy" ratings and raising price targets, including HC Wainwright, which set a price objective of $18.00.

Kingswood Wealth Advisors LLC raised its position in shares of Amprius Technologies, Inc. (NYSE:AMPX - Free Report) by 44.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 85,408 shares of the company's stock after purchasing an additional 26,389 shares during the period. Kingswood Wealth Advisors LLC owned approximately 0.07% of Amprius Technologies worth $360,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in AMPX. Bank of America Corp DE raised its position in Amprius Technologies by 31.1% during the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock valued at $36,000 after purchasing an additional 3,055 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Amprius Technologies by 61.1% during the first quarter. Rhumbline Advisers now owns 15,690 shares of the company's stock valued at $42,000 after buying an additional 5,951 shares during the last quarter. FNY Investment Advisers LLC bought a new position in shares of Amprius Technologies during the first quarter valued at about $298,000. Cornerstone Partners Capital Management LLC bought a new position in shares of Amprius Technologies during the first quarter valued at about $41,000. Finally, Oppenheimer & Co. Inc. grew its stake in shares of Amprius Technologies by 319.4% during the first quarter. Oppenheimer & Co. Inc. now owns 491,378 shares of the company's stock valued at $1,317,000 after buying an additional 374,228 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company's stock.

Insiders Place Their Bets

In other news, CEO Kang Sun sold 65,654 shares of the stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $6.82, for a total value of $447,760.28. Following the completion of the transaction, the chief executive officer owned 1,472,306 shares of the company's stock, valued at approximately $10,041,126.92. This represents a 4.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Sandra Wallach sold 28,390 shares of the stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $6.82, for a total value of $193,619.80. Following the completion of the transaction, the chief financial officer directly owned 1,005,275 shares of the company's stock, valued at $6,855,975.50. This represents a 2.75% decrease in their position. The disclosure for this sale can be found here. Insiders sold 113,203 shares of company stock worth $772,044 over the last three months. Company insiders own 12.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AMPX. HC Wainwright reaffirmed a "buy" rating and set a $18.00 price objective (up from $10.00) on shares of Amprius Technologies in a research note on Friday, August 8th. Roth Capital reaffirmed a "buy" rating and set a $10.00 price objective (up from $6.00) on shares of Amprius Technologies in a research note on Tuesday, August 5th. William Blair raised Amprius Technologies from a "market perform" rating to an "outperform" rating in a research note on Friday, July 18th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Wednesday. Finally, Northland Securities set a $20.00 price objective on Amprius Technologies in a research note on Tuesday. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $13.14.

Amprius Technologies Trading Down 6.8%

Amprius Technologies stock opened at $11.94 on Friday. The firm has a 50-day moving average of $9.07 and a 200-day moving average of $5.62. The firm has a market cap of $1.49 billion, a P/E ratio of -36.18 and a beta of 2.85. Amprius Technologies, Inc. has a 1-year low of $1.16 and a 1-year high of $14.07.

Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The company had revenue of $15.07 million during the quarter, compared to analyst estimates of $12.38 million. Amprius Technologies had a negative net margin of 84.77% and a negative return on equity of 55.79%. Research analysts forecast that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Amprius Technologies Profile

Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.